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Abstract 
At high altitude, barometric pressure falls and with it inspired PO2, potentially compromising O2 
delivery to the tissues. With sufficient acclimatisation, the erythropoietic response increases red 
cell mass such that arterial O2 content (CaO2) is restored; however arterial PO2 (PaO2) remains 
low, and the diffusion of O2 from capillary to mitochondrion is impaired. Mitochondrial 
respiration and aerobic capacity are thus limited, whilst reactive oxygen species (ROS) production 
increases. Restoration of PaO2 with supplementary O2 does not fully restore aerobic capacity in 
acclimatised individuals, possibly indicating a peripheral impairment. With prolonged exposure to 
extreme high altitude (>5500 m), muscle mitochondrial volume density falls, with a particular loss 
of the subsarcolemmal population. It is not clear whether this represents acclimatisation or 
deterioration, but it does appear to be regulated, with levels of the mitochondrial biogenesis factor 
PGC-1α falling, and shows similarities to adapted Tibetan highlanders. Qualitative changes in 
mitochondrial function also occur, and do so at more moderate high altitudes with shorter periods 
of exposure. Electron transport chain complexes are downregulated, possibly mitigating the 
increase in ROS production. Fatty acid oxidation capacity is decreased and there may be 
improvements in biochemical coupling at the mitochondrial inner membrane that enhance O2 
efficiency. Creatine kinase expression falls, possibly impairing high-energy phosphate transfer 
from the mitochondria to myofibrils. In climbers returning from the summit of Everest, cardiac 
energetic reserve (PCr/ATP) falls, but skeletal muscle energetics are well preserved, possibly 
supporting the notion that mitochondrial remodelling is a core feature of acclimatisation to 
extreme high altitude. 
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Abbreviations List 
 
31
P-MRS  phosphorus-31 magnetic resonance spectroscopy 
BNIP3   BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 
ETC   electron transport chain 
HIF   hypoxia-inducible factor 
HOAD   3-hydroxyacyl-CoA dehydrogenase 
PGC    peroxisome proliferator-activated receptor gamma co-activator 
PO2   partial pressure of O2 
PCr/ATP  phosphocreatine-to-adenosine triphosphate ratio 
PHD   prolyl-hydroxylase 
PPARα  peroxisome proliferator-activated receptor alpha 
ROS   reactive oxygen species 
SDF   sidestream darkfield [imaging] 
UCP3   uncoupling protein 3 
Vmax   maximum rate of mitochondrial oxygen consumption 
VO2max   maximum rate of whole-body oxygen consumption 
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Introduction 
Barometric pressure decreases with altitude and thus inspired PO2 falls, such that at high altitudes 
O2 delivery from the lungs to oxidative tissues such as heart and skeletal muscle is challenged. 
Within the body, the majority of oxygen consumption occurs at cytochrome c oxidase (complex 
IV) of the mitochondrial electron transport chain (ETC). The concept of symmorphosis postulates 
that biological systems are economical, with structural parameters matched to functional capacity 
(Weibel et al., 1991). Accordingly, in the case of the respiratory system, mitochondrial volume in 
the muscles would be proportional to total aerobic capacity (Weibel et al., 1991). Thus at high 
altitude, when aerobic capacity becomes limited, alterations in mitochondrial volume and function 
could intuitively form part of the process of human acclimatisation (Murray, 2014). Alternatively, 
the mitochondria might be viewed as potential targets of damage during the less well-understood 
process of high altitude deterioration (Ward, 1954) since they are sites of reactive oxygen species 
(ROS) production.  
 
Over the past 25 years, a number of studies have reported changes in mitochondrial volume 
density, subcellular distribution, oxidative enzyme activity and protein expression in the muscles 
of climbers returning from extreme high altitude (>5500 m) and these findings are reviewed here 
(Figure 1). Whilst no direct measures of mitochondrial function have yet been made above 5500 
m, phosphorus-31 magnetic resonance spectroscopy (
31
P-MRS) has been used by our research 
group to study heart and skeletal muscle energetics as an indirect measure of mitochondrial 
function in climbers at sea level, prior to and within a few weeks of their return from extreme 
altitude. In addition, a small number of informative studies of mitochondrial respiratory function 
have been made in permeabilised fibres of skeletal muscle biopsies at altitudes between 3400 and 
4500 m using high-resolution respirometry, and these findings have also been included here. 
Finally, whilst the focus of this review is on human mitochondrial function at extreme high 
altitude, reference is made to relevant mechanistic insights gleaned from high-altitude adapted 
species, experimental animal models and cells cultured under hypoxic conditions. For a more 
comprehensive account of the metabolic changes that occur in the skeletal muscle of rodents and 
humans in response to real or simulated altitudes >3000 m, we refer you to our recent review 
(Horscroft & Murray, 2014). 
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What underlies the possible change in mitochondrial function at extreme high altitude? 
Upon ascent to altitudes over 5500 m, barometric pressure, and thus inspired PO2, falls to less than 
half of that at sea level, with the inspired PO2 on the summit of Mt Everest (8848 m) being less 
than one-third of that at sea level (43.1 mmHg compared with 148.0 mmHg) (West et al., 1983). 
The successful ascent of Everest without supplementary oxygen by Reinhold Messner and Peter 
Habeler in 1978 (a feat repeated by Messner and others since), demonstrated the remarkable 
capacity of the human body to perform at such extreme altitude. It is clear that successful 
acclimatisation during a gradual ascent is paramount to any such attempt to reach extreme 
altitudes.  
 
Features of acclimatisation that improve O2 delivery at altitude have been well documented. Upon 
arrival at altitude, resting heart rate increases and cardiac output is elevated for a given amount of 
physical work. The sea-level relationship between cardiac output and workload is later restored as 
arterial O2 content (CaO2) returns to sea level values, although notably the maximum achievable 
cardiac output falls at higher altitudes (Peacock, 1998). Ventilatory aspects of acclimatisation 
show a distinct time course, with an initial increase in ventilation (the hypoxic ventilatory 
response) followed by a brief reduction back towards control values (hypoxic ventilatory decline) 
before a sustained period of acclimatisation, during which ventilation continues to increase for up 
to about two weeks (West et al., 2007). Meanwhile, an initial increase in haematocrit can result 
from a fall in plasma volume due to dehydration, but in response to sustained hypoxia the 
juxtaglomerular apparatus of the kidneys increases production of erythropoietin (EPO), which 
stimulates bone marrow to increase red cell output. EPO levels can rise within hours of arrival at 
altitude, but the increase in red cell mass can take several weeks (Peacock, 1998; West et al., 
2007). In the face of falling arterial PO2, and therefore haemoglobin-O2 saturation, the 
erythropoietic response allows CaO2 to be maintained at, or even above, sea level values up to 
7000 m, falling only at more extreme altitudes (Grocott et al., 2009). 
 
Whilst the process of acclimatisation can take many weeks, a prolonged stay at extreme high 
altitude can result in high altitude deterioration. This process is rather less well-understood than 
acclimatisation, but is characterised by weight loss (including muscle-wasting), poor appetite, 
lethargy, slow recovery from fatigue and possibly low systemic blood pressure (Ward, 1954). 
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Altitude exposure can decrease energy intake by as much as half (Guilland & Klepping, 1985; 
Rose et al., 1988), resulting in an energy deficit which underlies the loss of body mass (Westerterp 
& Kayser, 2006). The cachectic response to high altitude, whilst traditionally viewed as 
detrimental, may afford some protection though e.g. via the release of metabolic substrates and 
signalling molecules (Murray & Montgomery, 2014; Levett et al., 2015), an increased ratio of 
capillaries to muscle fibre cross sectional area (Hoppeler et al., 1990a) or simply by decreasing 
whole-body O2 demand due to the loss of body mass. Changes in diet and energy balance are 
therefore confounding factors, which must be considered in studies of metabolism at extreme 
altitude. 
 
Even with adequate acclimatisation, though, and a CaO2 equivalent to that at sea level, exercise 
capacity and VO2max are impaired at altitude (Cerretelli, 1976; Levett et al., 2011; Levett et al., 
2012). Moreover, the loss of VO2max at any given altitude is not discernibly different between 
unacclimatised and fully-acclimatised subjects (Cerretelli, 1976). Thus, whilst successful 
acclimatisation can help to stave off some of the potentially adverse consequences of high altitude 
(most notably, acute mountain sickness) (West et al., 2007), exercise capacity is not improved. 
This somewhat counterintuitive finding illustrates the importance of capillary PO2, as opposed to 
CaO2, in supporting O2 transport and utilisation. Convective O2 delivery is restored by 
acclimatisation, but since capillary PO2 remains low, the capacity for diffusion between the 
capillary and mitochondrion is limited – a concept proposed by Peter Wagner and co-workers 
(Wagner, 1996, 2000), and supported by experimental evidence in hypoxic dogs (Hogan et al., 
1988) and retrospective analysis of data collected from human subjects during Operation Everest 
II, in which subjects underwent progressive decompression to the equivalent of 8898 m in a 
chamber at sea level (Sutton et al., 1988; Wagner, 2010). Whilst muscle wasting at altitude might 
conceivably improve diffusion to the mitochondria by decreasing mean diffusion distance, in dogs 
with muscle wasting following leg immobilisation, O2 conductance was not improved (Hepple et 
al., 2000). 
  
At extreme high altitude, therefore, capillary PO2 is decreased, even in fully acclimatised subjects. 
What then of the mitochondrial PO2? Measurements of the distribution of PO2 within working 
skeletal muscle fibres suggest a sharp immediate fall in PO2 at the interface between capillary and 
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myocyte, but with the PO2 across the remaining width of the myocyte being reasonably uniform 
and low, due to the presence of myoglobin in aiding distribution (Gayeski & Honig, 1986a, b). 
Within the mitochondrion itself, at cytochrome c oxidase (the terminal complex of the ETC and 
site of O2 consumption) PO2 is extremely low; probably less than 1 mmHg (0.13 kPa) even in the 
absence of environmental hypoxia (Chance, 1957; Chance et al., 1962). As such, mitochondrial 
PO2 has often been considered negligible and thus assumed to be zero in many models of O2 
diffusion and consumption. This assumption cannot however be correct, since oxidative 
phosphorylation is dependent upon O2, and if PO2 were zero then so too would be VO2 (Cano et 
al., 2013). A recently-refined model of whole-body O2 transport and utilisation has allowed for 
greater heterogeneity in PO2 across muscle regions, with mitochondrial PO2 increasing under 
conditions where mitochondrial respiratory capacity (Vmax) is relatively low compared with O2 
delivery (Cano et al., 2015). Using data from Operation Everest II, the model predicts a 
progressive fall in mitochondrial PO2 of exercising muscle at altitude, from around 1 mmHg at sea 
level to a mean value of 0.119 mmHg on the summit of Everest (Cano et al., 2015). This is below 
measurements made in vitro of the P50 of mitochondrial respiration (Gnaiger et al., 1998) and as 
such respiration would be limited. In addition, another expected consequence of such low 
mitochondrial PO2 at extreme altitude, would be a sharp increase in ROS production (Cano et al., 
2014), the implications of which are discussed later in this review. 
 
The fall in arterial (and thus capillary) PO2 at extreme altitude thus limits O2 diffusion, 
exaggerating the mismatch between the capacity of the tissue to consume available O2 (Vmax) and 
the capacity to deliver it - a situation already present to some degree in humans at sea level 
(Boushel et al., 2011) and seeming to contradict the concept of symmorphosis (Weibel et al., 
1991). At altitude, VO2max can be improved by the use of O2 supplementation to elevate arterial 
(and thus capillary) PO2, but curiously it is not completely restored to sea level values in 
acclimatised subjects, despite their elevated haematocrit which actually results in them having an 
enhanced CaO2 compared with that at sea level (Cerretelli, 1976). This finding provided the 
earliest evidence for a peripheral impairment either in local O2 delivery, as Paolo Cerretelli 
suggested at the time, or in the oxidative capacity of the muscle – a subject that was to form the 
basis of much of his later research (Ferretti, 2003). In further support of this, VO2max does not 
return to pre-expedition values for several weeks after acclimatised subjects return to sea level 
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(Grassi et al., 1996). Intriguingly, recent measures of impaired blood flow through the sublingual 
microvasculature using sidestream darkfield (SDF) imaging suggest that local O2 delivery might 
indeed be worsened in acclimatised subjects at altitude (Martin et al., 2009), perhaps due to 
increased blood viscosity secondary to a raised haematocrit or endothelial dysfunction. It should, 
however, be noted that comparable measures have not yet been made in the skeletal muscle 
microcirculation and it remains a question as to how generalisable this finding is. 
 
Morphological changes in mitochondria – volume density and subcellular distribution 
Altitude thus poses a sustained challenge to oxidative phosphorylation. An interpretative 
hypothesis, based on observational data from the muscles from high-altitude adapted animals had 
previously suggested that an enhanced oxidative capacity was a necessary component of high 
altitude acclimatisation (Hochachka et al., 1983). This was supported by earlier evidence of high 
oxidative capacities and myoglobin concentrations in the sartorius muscle of some Andean 
highlanders compared with lowlanders (Reynafarje, 1962), however these measurements may have 
been confounded by differences in training status between subjects. Endurance training is a potent 
stimulant for mitochondrial biogenesis, and was found to be as effective in Andean natives as it is 
in lowland residents (Desplanches et al., 1996). Certainly in lowlanders acclimatising to high 
altitude this is not the case; oxidative capacities fall with prolonged exposure, and at extreme 
altitude the mitochondrial volume density of human skeletal muscle decreases. A loss of 20-30% 
of mitochondrial density has consistently been seen in climbers returning from the summit of 
Everest (Hoppeler et al., 1990a; Levett et al., 2012), alongside the accumulation of lipofuscin, a 
substance believed to result from lipid peroxidation and thus indicating possible oxidative stress 
(Howald & Hoppeler, 2003). It is tempting to view this phenomenon as a feature of high altitude 
deterioration; interestingly, there was no apparent loss of mitochondria in the muscles of the 
subjects of Operation Everest II (MacDougall et al., 1991) whose rapid ascent to the equivalent 
altitude of the summit of Everest (over 40 days) and immediate return to normal barometric 
pressure (Houston et al., 1987) limited their exposure to extreme altitude in comparison with a 
traditional Everest expedition. Intriguingly though, in muscle biopsies from Sherpas, a highly-
adapted subgroup of native Tibetan highlanders reputed to be strong performers at extreme altitude 
(Gilbert-Kawai et al., 2014), lower mitochondria densities have also been reported (Kayser et al., 
1991) and this also appears to be the case in lowland-dwelling Tibetans that have never resided at 
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altitude (Kayser et al., 1996). Perhaps, therefore, the loss of mitochondrial density in acclimatising 
lowlanders is an adaptive response that mimics the adaptations of high altitude natives, rather than 
simple deterioration. 
 
Curiously, there appear to be differential effects of extreme altitude on two discrete subpopulations 
of mitochondria in human muscle. Within the cell, mitochondria do not generally exist as distinct, 
individual, rod-shaped organelles, but instead form a dynamic reticular network, which undergoes 
continual fusion and fission (Picard et al., 2011). Within skeletal and cardiac muscle, this network 
forms spatially-distinct pools, with a subpopulation of subsarcolemmal mitochondria lying 
alongside the cell membrane and interfibrillar mitochondria positioned in rows alongside the 
myofibrils (Ferreira et al., 2010; Hollander et al., 2014). In climbers returning from extreme 
altitude, there is a greater percentage loss of the less-abundant subsarcolemmal mitochondria than 
the more populous, deep-lying interfibrillar mitochondria (Hoppeler et al., 1990b; Levett et al., 
2012) (Figure 2). Correspondingly, whilst the lower mitochondrial density in Tibetans compared 
with lowland Nepalese appears to be driven by lower densities of both subsarcolemmal and 
interfibrillar mitochondria, a greater component of the difference is accounted for by the lower 
subsarcolemmal population (Kayser et al., 1996). These findings are somewhat counter-intuitive, 
as a selective loss of the subsarcolemmal population, would result in a potentially 
counterproductive increase in mean diffusion distance for O2 between the capillary and remaining 
(largely interfibrillar) mitochondria. This may in part be mitigated by an increase in capillary 
density, due to muscle fibre wasting (Hoppeler et al., 1990a; Ferretti, 2003; Murray & 
Montgomery, 2014), and possibly by an increased myoglobin content to facilitate intracellular O2 
diffusion. Increased myoglobin levels have been reported in rodents exposed to environmental 
hypoxia (Clark et al., 1952; Vaughan & Pace, 1956) and dogs residing at high-altitude (Hurtado et 
al., 1937). In humans, however, the picture is less clear. Elevated myoglobin levels were reported 
in some high altitude natives (Reynafarje, 1962), although again this observation may have been 
confounded by training status. Expression levels of myoglobin were not increased in climbers 
returning from the summit of Everest though (Levett et al., 2015), and may only become 
upregulated when exercise training is imposed on top of the hypoxic stimulus (Hoppeler & Vogt, 
2001; Desplanches et al., 2014). Moreover, in one study muscle levels of myoglobin fell by 35% 
in human subjects after 7-9 days at 4559 m, alongside the downregulation of other iron-related 
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proteins and loss of total muscle iron content – effects that were attributed to the need to mobilise 
intramuscular iron to support the erythropoietic response (Robach et al., 2007). 
 
The subcellular distribution of mitochondria is not, however, only important for the diffusion of O2 
but also for the exchange of the high-energy phosphate products of respiration between the 
mitochondrial source and the myofibrils (Hoppeler & Billeter, 1991). The latter process is aided in 
highly-oxidative tissues such as cardiac and skeletal muscle by the creatine kinase shuttle, which 
acts as a temporal and spatial buffer of cellular ATP by transferring phosphate from ATP to 
creatine at the mitochondrion, forming phosphocreatine and ADP, and catalysing the reverse 
reaction at the myofibrils. These reactions maintain [ADP] at the mitochondrion, supporting 
respiration, and [ATP] at myosin, supporting contraction. The creatine kinase shuttle also allows a 
faster distribution of the high-energy phosphate from the mitochondrion to myofibril as the smaller 
phosphocreatine molecule diffuses more rapidly than ATP. At altitude, however, creatine kinase is 
downregulated (Vigano et al., 2008; Levett et al., 2015), potentially impairing high-energy 
phosphate transfer. Muscle fibre wasting may mitigate this to some extent, by decreasing average 
diffusion distances, but it is possible that with a compromised capacity for phosphocreatine 
synthesis the preferred maintenance of mitochondria in intermyofibrillar regions circumvents some 
of the resulting limitations of high-energy phosphate delivery to myosin. 
 
In contrast with humans, in the muscles of certain species of bird adapted for flight at extreme high 
altitudes, such as the bar-headed goose, a greater overall aerobic capacity is accompanied by a 
preponderance of subsarcolemmal mitochondria (Figure 2); an adaptation presumed to be 
beneficial in minimising O2 diffusion distance (Scott, 2011). Training status may be a confounding 
factor here too though, since the low air density at these altitudes increases the work required to 
generate the lift and thrust to maintain flight (Bishop et al., 2015). It should be noted, however, 
that mitochondrial ATP production in these birds is more strongly regulated by the creatine kinase 
shuttle than in low altitude-dwelling species (Scott et al., 2009). Perhaps this suggests that the 
geese have a more effective high-energy phosphate delivery mechanism than man, obviating the 
need for a more substantial population of interfibrillar mitochondria and allowing redistribution of 
mitochondria to the cell periphery. Moreover, these birds exhibit other adaptations, including high 
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muscle capillarity and an enhanced hypoxic ventilatory response, which would partly counteract 
the fall in arterial PO2 at these altitudes (Scott, 2011).  
 
The physiological significance of the apparent selective loss of subsarcolemmal mitochondria in 
humans at extreme altitude remains unclear, whilst the mechanism regulating it is undetermined. 
Indeed little is firmly known about the functional importance of these two subpopulations, 
although in some rat muscles (but not all) they have different respiratory capacities (Palmer et al., 
1977; Philippi & Sillau, 1994) and differences in the proteome of the two subpopulations has also 
been noted (Ferreira et al., 2010). In humans at sea level, it is notable that the subsarcolemmal 
population is associated with much greater changes in volume density in response to endurance 
training than the interfibrillar mitochondria (Desplanches et al., 1993). It is possible that the loss of 
mitochondrial density, and in particular the subsarcolemmal population with prolonged exposure 
to extreme high altitude may therefore simply represent a detraining response accompanying the 
lethargy associated with high altitude deterioration, rather than true acclimatisation. Moreover, the 
cachectic response to high altitude and changes in diet may also affect mitochondrial density and 
distribution. In cells, however, and increasingly in animal models and human subjects, there is 
evidence of regulated transcriptional modification of metabolism and mitochondrial density 
associated with hypoxic exposure, and this evidence is reviewed in the next section. 
 
Regulation of mitochondrial density in prolonged hypoxia 
The cellular response to hypoxia is predominantly governed by the hypoxia-inducible factor (HIF) 
family of transcription factors. HIF-1α and 2α subunits are constitutively-expressed, but degraded 
following O2-dependent hydroxylation by prolyl-hydroxylase enzymes (PHD1-3) (Semenza, 
2007). At low tissue PO2, the HIF α-subunits are thus stable and dimerise with the nuclear HIF-1β 
subunit, activating the transcription of genes which contain hypoxia-response elements in their 
promoter regions, including those encoding EPO and vascular endothelial growth factor (VEGF) 
(Semenza, 2007). There appears to be a timing-dependent component to this response, termed the 
HIF switch, whereby HIF-1 stabilisation underpins an initial response to hypoxia (<24 h) whilst 
the more sustained response is supported by HIF-2 (Koh & Powis, 2012). Systemically, HIF-2 
activation underlies the erythropoietic response, whilst in cultured cells HIF-1-dependent measures 
to decrease O2 demand include the down-regulation of mitochondrial oxidative phosphorylation 
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via pyruvate dehydrogenase inhibition (Kim et al., 2006). A HIF-dependent upregulation of the 
pro-apoptotic protein, BNIP3, also underlies a process of mitochondrial autophagy, and 
consequent loss of mitochondrial density, in some cells (Zhang et al., 2008). An increase in BNIP3 
appears to occur in the hypoxic rat heart (Regula et al., 2002), but was not seen in human muscle 
at extreme altitude, though markers of chaperone-mediated autophagy were present (Levett et al., 
2015) (Figure 3). 
 
In skeletal muscle, there is a possible interaction between the transcriptional activity of HIF and 
that of the mitochondrial biogenesis factor, peroxisome proliferator-activated receptor γ co-
activator 1α (PGC-1α). In cultured myocytes, PGC-1α overexpression increased mitochondrial 
biogenesis and thus cellular O2 consumption, causing a fall in tissue PO2, which in turn stabilised 
HIF-1α (O'Hagan et al., 2009) (Figure 3). Conversely, in renal carcinoma cells with constitutively-
stabilised HIF-1, mitochondrial biogenesis was suppressed secondary to repression of C-MYC 
activity and decreased expression of PGC-1β (Zhang et al., 2007). Thus mitochondrial density is 
dynamically-regulated in response to O2 availability, with mitochondrial biogenesis supported 
when O2 is available (and HIF-1 therefore not stabilised) but further mitochondrial biogenesis 
inhibited if cellular O2 consumption increases to the extent that PO2 falls below a critical point and 
HIF-1 becomes stabilised. Levels of PGC-1α were decreased in climbers returning from the 
summit of Everest and biopsied at 5300 m, suggesting a suppression of mitochondrial biogenesis 
had occurred (Levett et al., 2012). HIF-1α levels were not elevated in these subjects, although in 
line with the HIF switch this would not perhaps have been expected after 66 days exposure. 
Unfortunately, levels of HIF-2α, which mediates the more sustained response to hypoxia, were not 
measured in these subjects. In the same study, subjects biopsied within a few days of arrival at 
5300 m following ascent, did show enhanced HIF-1α, but no loss of mitochondrial density or 
PGC-1α at this stage (Levett et al., 2012). 
 
Interestingly, the altitude-dependent loss of mitochondria and remodelling of mitochondrial 
function do appear to be dependent on length of exposure as well as altitude reached (Horscroft & 
Murray, 2014), perhaps reflecting a time-dependent regulation of the transcriptional response in 
line with the HIF-switch. Notably, in two studies from Carsten Lundby’s group, which used high-
resolution respirometry to measure respiratory function in skeletal muscle biopsies, relatively 
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short-term exposure (9-11 days) to 4559 m had no discernible effect on mitochondrial respiratory 
capacity (Jacobs et al., 2013), whilst 28 days exposure to a lower altitude (3454 m) did result in a 
diminished respiratory capacity, albeit in the absence of a change in mitochondrial content (Jacobs 
et al., 2012). The findings from these studies are discussed in more detail in the next section. 
 
Mitochondria themselves play a further, critical role in hypoxia-signalling, forming the nexus of a 
feedback loop that maintains cellular redox homeostasis. Under hypoxic conditions, electron leak, 
particularly from complexes I and III of the highly-reduced mitochondrial ETC, leads to increased 
production of ROS, such as the superoxide radical (O2
.-
), potentially damaging proteins, lipids and 
DNA and thus impairing cellular function (Guzy & Schumacker, 2006; Tsutsui, 2006). ROS 
production is predicted to rise with altitude, increasing rapidly at altitudes above 7000 m (Cano et 
al., 2014). Oxidative stress enhances HIF stabilisation in cells (Chandel et al., 2000; Guzy et al., 
2005; Guzy & Schumacker, 2006), thereby activating responses that in turn curb ROS generation, 
albeit at the possible cost of impaired ATP synthesis (Murray, 2009). A HIF-regulated process of 
mitophagy or repression of mitochondrial biogenesis, in matching tissue O2 demand to a 
diminished supply, is thought to limit ROS production, thereby protecting the remaining 
mitochondria and preserving their respiratory function. Paradoxically, there is also evidence that 
ROS are necessary mediators for training-induced mitochondrial biogenesis though (Gomez-
Cabrera et al., 2008). These apparently opposing effects, may be determined by the duration of the 
ROS-stimulus, with an acute increase in ROS during exercise eliciting mitochondrial biogenesis, 
but sustained ROS production with chronic exposure to extreme altitude repressing biogenesis and 
activating mitophagy. 
 
Qualitative changes in mitochondrial function – oxidative enzymes and respiratory coupling 
Mitochondrial respiratory function itself exhibits plasticity under prolonged/severe hypoxia, 
beyond a modulation of mitochondrial content, with changes in substrate metabolism, ETC 
activity and respiratory coupling occurring in response to extreme high altitude, but also at more 
moderate high altitude over shorter periods of exposure when there may not yet be a loss of 
mitochondrial density (Horscroft & Murray, 2014). Regarding extreme altitude, the activity and/or 
expression of a number of TCA Cycle enzymes have been found to be downregulated following 
real or simulated ascent above 5500 m, including citrate synthase (Green et al., 1989; Howald et 
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al., 1990; Levett et al., 2012), isocitrate dehydrogenase (Levett et al., 2015), α-ketoglutarate 
dehydrogenase (Levett et al., 2015) and succinate dehydrogenase (Green et al., 1989; Levett et al., 
2015), which also comprises complex II of the ETC. Of the other ETC complexes, decreased 
protein levels or activity of subunits of complex I (Levett et al., 2012), complex III (Levett et al., 
2015) and complex IV (Howald et al., 1990; Levett et al., 2012) have all been reported following 
exposure to extreme altitude. Furthermore, in high-resolution respirometry studies of 
permeabilised muscle fibres, respiration capacity for both complex I and complex II substrates 
were decreased following 28 days at 3454 m with no loss in citrate synthase activity (Jacobs et al., 
2012), but no such changes were seen with short-term exposure to 4559 m (Jacobs et al., 2013). 
Downregulation of ETC complexes under hypoxic conditions, may mitigate the potential rise in 
ROS production via electron leak, by restricting electron entry into the chain. In hypoxic human 
fibroblasts, upregulation of a HIF-regulated microRNA, miR-210, suppressed the expression of 
ETC complex assembly proteins, decreasing the levels and respiratory capacity of complexes I and 
IV (Colleoni et al., 2013). This effect was also seen in human placentas at 3100 m (Colleoni et al., 
2013) and may explain the downregulation of these two complexes in the muscle of climbers 
returning from the summit of Everest (Levett et al., 2012) (Figure 4). 
 
A further possible adaptive response might be one of improved mitochondrial O2 efficiency, 
resulting from a substrate switch away from fatty acid oxidation towards more O2-efficient glucose 
oxidation, and a possible improvement in mitochondrial coupling. The capacity for fatty acid 
oxidation tends to fall at high altitude (Horscroft & Murray, 2014), with decreased activity of 3-
hydroxyacyl-CoA dehydrogenase (HOAD) (Levett et al., 2012) and protein levels of a number of 
other β-oxidation enzymes (Levett et al., 2015) reported in climbers following ascent of Everest 
(Figure 4). HOAD activities were also lower in Tibetans compared with lowland Nepalese (Kayser 
et al., 1996). A number of these enzymes are transcriptional targets for a fatty acid-activated 
transcription factor, peroxisome proliferator-activated receptor α (PPARα), which, at least in some 
tissues, is downregulated in hypoxia in a HIF-dependent manner (Narravula & Colgan, 2001). 
Notably, however, protein levels of pyruvate dehydrogenase were also lower in these subjects 
post-Everest, perhaps arguing against a switch towards glucose oxidation and instead supporting a 
possible increased role for glycolytic ATP production and lactate production instead, bypassing 
the mitochondria.  
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With the downregulation of oxidative enzymes and loss of mitochondrial density, it is conceivable 
that anaerobic glycolysis might make a greater contribution to muscle ATP demands at extreme 
altitude, particularly during exercise. The genes for many glycolytic enzymes contain hypoxia-
response elements in their promoter regions (Semenza et al., 1994), and in hypoxic cells, the 
inhibition of pyruvate dehydrogenase (Kim et al., 2006) supports a Pasteur Effect, in which 
glycolytically-derived lactate is expelled from the cell. In humans, however, the evidence to 
support increased glycolysis at altitude is limited (Horscroft & Murray, 2014). Indeed, in muscle 
biopsies from humans returning from extreme altitude, the levels of several glycolytic enzymes 
were decreased (Levett et al., 2015) as was hexokinase activity (Levett et al., 2012). These 
observations might reflect the so-called ‘lactate paradox’. In this phenomenon, acute exposure to 
high altitude is accompanied by greater blood lactate levels ([Lab]) at a given submaximal 
workload than at sea level, however following acclimatisation over a period of weeks, the same 
exercise challenge results in a lower [Lab], more comparable with that at sea level (West, 1986). 
Thus, acclimatisation may decrease the initial dependence on glycolysis to meet cellular ATP 
demand, perhaps through multiple adjustments that optimise O2 delivery and utilisation or through 
better coupling of pyruvate production and oxidative phosphorylation. Some studies, however, 
have suggested that the ‘lactate paradox’ is a more transient feature of acclimatisation and not 
applicable to those spending longer durations at extreme altitude (Lundby et al., 2000; van Hall et 
al., 2001; van Hall et al., 2009).  
 
The notion of improved respiratory coupling, resulting in enhanced O2 efficiency at extreme 
altitude is also appealing, though it should be noted that mitochondrial uncoupling is likely to 
afford some antioxidant protection and may thus be beneficial. Levels of uncoupling protein 3 
(UCP3), another PPARα target, decreased in the muscle of climbers following an ascent of Everest 
(Levett et al., 2012), and whilst the possible effects of UCP3 on mitochondrial efficiency do 
remain controversial, it is notable that in high-resolution respirometry studies LEAK state 
respiration (a functional measure of uncoupling) decreased in subjects after a month at 3454 m 
(Jacobs et al., 2012) (Figure 4). UCP3 levels correlated negatively with some measures of cycling 
efficiency in athletes at sea level (Mogensen et al., 2006), but the question of whether improved 
mitochondrial coupling at altitude translates into enhanced exercise efficiency remains 
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controversial, with some studies showing improvements (Gore et al., 2007; Latshang et al., 2013) 
and others showing no change in economy (Lundby et al., 2007). The regulation of mitochondrial 
efficiency, and indeed exercise efficiency, may occur independently of changes in gene 
transcription though with improvements in phosphorylation efficiency measured in rat liver 
mitochondria (Gnaiger et al., 2000) and human muscle mitochondria (Schiffer et al., 2014) when 
respiration was measured under acute hypoxic conditions. In contrast with these mitochondrial 
changes, however, in the same study of human subjects gross efficiency actually decreased with 
exercise in acute hypoxia (Schiffer et al., 2014), perhaps suggesting an influence from factors 
other than mitochondrial efficiency e.g. different muscle fibre recruitment or the additional 
energetic cost of ventilation under hypoxic conditions. 
 
Energetic and functional consequences of mitochondrial remodelling at extreme high 
altitude 
The energetic and functional consequences of altitude-induced mitochondrial remodelling are 
difficult to firmly establish. Using 
31
P-MRS, we found altered skeletal muscle energetics in 
climbers within 48 hours of returning to sea level from altitudes > 7950 m, following a total of 10-
17 days descent. Changes included an increase in the free energy available from ATP hydrolysis, 
and lower resting ADP concentrations (Edwards et al., 2010). There was no change in resting 
phosphocreatine levels, nor phosphocreatine recovery half-time (taken to represent mitochondrial 
function) following a plantar flexion exercise, but this re-synthesis of phosphocreatine appeared to 
be more tightly regulated, with no overshoot in phosphocreatine production post-exercise 
(Edwards et al., 2010). Overall, however, it is remarkable how well preserved energy metabolism 
was in these subjects throughout an exercise challenge, in the face of significant skeletal muscle 
atrophy (Edwards et al., 2010), loss of mitochondrial density (Levett et al., 2012) and 
downregulation of creatine kinase (Levett et al., 2015). Whilst enhanced glycolytic ATP 
production may contribute, muscle pH post-exercise was no lower following altitude exposure 
(Edwards et al., 2010). Our findings may instead indicate that the loss of mitochondrial density in 
these subjects was within the excess capacity known to exist in human muscle at sea level 
(Boushel et al., 2011). Interestingly, many of the changes seen following exposure to extreme 
altitude were recapitulated in subjects ascending no higher than 5300 m and spending less than 
three weeks at altitude (Edwards et al., 2010), an ascent profile which one would not expect to 
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have resulted in a loss of mitochondria. Such maintenance of energetic function would support a 
notion of acclimatisation, rather than detrimental deterioration.  
 
In parallel experiments on some of the same climbers returning from the summit of Everest, a loss 
of cardiac energetic reserve (PCr/ATP) was also seen, in association with impaired left ventricular 
filling during diastole (Holloway et al., 2011). Whilst it would be tempting to view this as 
deterioration, a similar loss of PCr/ATP has also been seen in trekkers returning from a relatively 
short sojourn to 5300 m (Holloway et al., 2011; Holloway et al., 2014). Meanwhile, the Sherpa 
heart was found to have a lower PCr/ATP than that of lowlanders, perhaps indicating that this 
lower energetic reserve results from a beneficial adaptation (Hochachka et al., 1996). For obvious 
practical reasons, it has not been possible to establish whether a loss of cardiac mitochondrial 
density or qualitative changes in cardiac mitochondrial function occur in humans at extreme 
altitude, but studies in rats have shown that 14 days hypoxic exposure (at 11 or 13% O2) decreases 
cardiac ATP levels, fatty acid oxidation capacity and ETC complex I activity, with no loss in 
cardiac mitochondrial content over this time (Heather et al., 2012; Ashmore et al., 2014). 
 
Conclusions 
Prolonged exposure to extreme high altitude results in a loss of mitochondrial volume density in 
skeletal muscle, with a modulation in function of the remaining mitochondria characterised by a 
loss of oxidative capacity, particularly for fatty acid substrates, and a possible improvement in 
biochemical coupling at the inner mitochondrial membrane. Such qualitative changes in 
mitochondrial function are also seen at more moderate high altitudes, in the absence of changes in 
mitochondrial volume density. It is not clear whether such changes should be considered a feature 
of acclimatisation or deterioration, and indeed both aspects may be present, but the changes do 
appear to be regulated and similarities between the metabolic phenotype of the acclimatised 
lowlander and adapted Tibetan highlander (e.g. decreased mitochondrial density particularly from 
subsarcolemmal mitochondria, decreased fatty acid oxidation) add support to this notion. Whilst 
impaired cardiac energetics have been reported in climbers returning from extreme high altitude, it 
is notable that skeletal muscle energetics are largely preserved during an exercise challenge, 
despite significant muscle atrophy, further supporting the concept of mitochondrial remodelling as 
a core feature of acclimatisation to extreme high altitude. 
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Figure Legends 
 
Figure 1 Timeline of key events and studies pertaining to the study of mitochondrial 
function in heart and skeletal muscle at extreme high altitude and discussed in 
this review. 
 
Figure 2 Subcellular distribution of mitochondria within the myocyte in A) 
unacclimatised lowlanders, B) acclimatised lowlanders or adapted Tibetan 
highlanders, C) adapted bar-headed geese. Acclimatisation in humans is 
associated with a greater loss of subsarcolemmal mitochondria, compared with the 
interfibrillar population. Meanwhile high altitude adapted Tibetans have lower 
mitochondrial densities than lowlanders with a greater proportion of the difference 
being account for by a relatively low subsarcolemmal population. Hence, high 
altitude acclimatisation appears to mimic the adapted-highlander phenotype. In bar-
headed geese, however, there is a preponderance of subsarcolemmal mitochondria, 
which appears to minimise the diffusion distance for O2. Bar-headed geese appear 
to have an enhanced creatine kinase shuttle, to aid the distribution of high-energy 
phosphate metabolites throughout the myocyte, whereas in humans at altitude, 
creatine kinase is downregulated. 
 
Figure 3 Possible mechanism underlying the regulation of mitochondrial volume 
density in response to cellular hypoxia at extreme high altitude. Under 
normoxic conditions (relatively high PO2), the hypoxia-inducible factors (HIFs) are 
hydroxylated and degraded, whilst under hypoxic conditions (low PO2) they are 
stabilised, with increased mitochondrial ROS production enhancing HIF stability. 
HIF binds to hypoxia response elements on target genes activating transcription. 
Hypoxia can therefore increase mitophagy factors (e.g. BNIP3) and lead to the 
downregulation of factors that stimulate mitochondrial biogenesis (e.g. PGC-1α). 
Thus, in sustained hypoxia, mitochondrial density falls, whereas in normoxic 
conditions mitochondrial biogenesis can be supported. An expanded population of 
mitochondria will consume O2 at a greater rate, decreasing cellular PO2 and leading 
to HIF stabilisation, whereas a loss of mitochondria will conversely restore PO2 
leading to HIF degradation. Thus the cell’s capacity for oxygen consumption (i.e. 
mitochondrial density) is dynamically coupled to tissue PO2, and oxygen demand 
therefore matched to supply. 
 
Figure 4 Summary of intramitochondrial changes that occur during acclimatisation to 
extreme high altitude. Studies at extreme high altitude have shown changes in 
enzyme activities and protein levels that suggest downregulation of electron 
transport chain (ETC) complexes, TCA cycle enzymes and substrate oxidation 
enzymes, alongside decreased levels of uncoupling protein 3 (UCP3). High 
resolution-respirometry of human muscle fibres at more moderate high-altitude has 
shown that sustained hypoxia is associated with decreased electron entry into the 
ETC and improved mitochondrial efficiency. 
 
